Immunotherapy of murine colon cancer using receptor tyrosine kinase EphA2-derived peptide-pulsed dendritic cell vaccines. Sep 2007 - Cancer; 110(7):0008-543X [PMID:17685394] [Yamaguchi S] [Tatsumi T] [Takehara T] [Sakamori R] [Uemura A] [Mizushima T] [Ohkawa K] [Storkus WJ] [Hayashi N]
Quick generation of fully mature dendritic cells from monocytes with OK432, low-dose prostanoid, and interferon-alpha as potent immune enhancers. Dec 2005 - J. Immunother.; 29(1):1524-9557 [PMID:16365602] [Sakakibara M] [Kanto T] [Inoue M] [Kaimori A] [Yakushijin T] [Miyatake H] [Itose I] [Miyazaki M] [Kuzushita N] [Hiramatsu N] [Takehara T] [Kasahara A] [Hayashi N]
Natural killer cells in hepatitis C virus infection: from innate immunity to adaptive immunity. Nov 2005 - Clin. Gastroenterol. Hepatol.; 3(10 Suppl 2):1542-3565 [PMID:16234066] [Takehara T] [Hayashi N]
Generation of hepatitis C virus-specific cytotoxic T lymphocytes from healthy individuals with peptide-pulsed dendritic cells. Jun 2001 - J. Gastroenterol. Hepatol.; 16(3):0815-9319 [PMID:11339423] [Ito A] [Kanto T] [Kuzushita N] [Tatsumi T] [Sugimoto Y] [Miyagi T] [Takehara T] [Katayama K] [Mochizuki K] [Hiramatsu N] [Kasahara A] [Yoshiya I] [Sasaki Y] [Hori M] [Hayashi N]
